Related Experiment Video
Updated: Dec 7, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Trends of utilization and outcomes after transcatheter and surgical aortic valve replacement on chronic dialysis
Tomo Ando1, Alexandros Briasoulis2, Hisato Takagi3
1Division of Cardiology, Center for Interventional Vascular Therapy, New York-Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA.
Insights
Transcatheter aortic valve replacement (TAVR) utilization increased significantly in patients on chronic dialysis (CD), surpassing surgical aortic valve replacement (SAVR). However, outcomes require improvement for this high-risk group.
Area of Science:
- Cardiology
- Interventional Cardiology
- Nephrology
Background:
- Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are crucial for aortic valve stenosis.
- Patients on chronic dialysis (CD) represent a high-risk population for these procedures.
- Limited data exists on the utilization and outcomes of TAVR versus SAVR in CD patients.
Purpose of the Study:
- To evaluate the trends in utilization of TAVR and SAVR.
- To compare the in-hospital outcomes of TAVR and SAVR in patients with CD.
- To identify potential areas for improving aortic valve replacement outcomes in CD patients.
Main Methods:
- Analysis of the Nationwide Readmission Databases from 2013 to 2017.
- Identification of TAVR and SAVR procedures using ICD-CM codes.
- Multivariable regression analysis to compare outcomes, including adjusted odds ratios (aOR) and 95% confidence intervals (CI).
Main Results:
- TAVR utilization increased four-fold, while SAVR increased 33% among CD patients.
- TAVR volume surpassed SAVR in CD patients by 2016-2017.
- In-hospital mortality remained similar for TAVR but increased for SAVR; however, 2017 data showed higher mortality and readmission for TAVR in CD versus non-CD patients.
Conclusions:
- TAVR use has significantly increased in patients on chronic dialysis.
- Despite increased utilization, outcomes for TAVR in CD patients warrant further investigation and improvement.
- There is a continued need to optimize aortic valve replacement strategies for the CD population.
Background And Aim:
Trends of utilization and outcomes of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) for patients on chronic dialysis (CD) are not well described. We aimed to assess the trends in utilization and outcomes of TAVR and SAVR on CD.
Methods:
Nationwide Readmission Databases from 2013 to 2017 was analyzed. International Classification of Diseases Clinical Modification 9 and 10 codes were used to identify diagnoses and procedures. A multivariable regression model was used to compare the outcomes expressed as adjusted odds ratio (aOR) and 95% confidence interval (CI).
Results:
A total of 5731 TAVR and 6491 SAVR were performed in patients with CD, respectively. The volume of TAVR increased by approximately four-folds and SAVR increased by approximately 33%. However, amongst patients with CD, the percentage of TAVR increased, whereas that of SAVR decreased (p < .001 for all). In 2016 and 2017, TAVR volume surpassed that of SAVR on CD. In-hospital mortality remained similar in TAVR (aOR: 0.92; 95% CI: 0.79-1.07; p-trend = .23) whereas it increased significantly in SAVR (aOR: 1.14: 95% CI: 1.05-1.25, p-trend = .002). In 2017, in-hospital mortality and 30-day readmission were significantly higher in TAVR among CD than non-CD patients.
Conclusion:
Despite increased use of TAVR among CD, there still is an opportunity for improvement in outcome of aortic valve replacement for those on CD.
More Related Videos
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Aortic Regurgitation III: Medical Management
Continuous Renal Replacement Therapy
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis III: Nursing Management

